Three of those genes, PCNA, ATP5C1, and NUSAP1, were confirmed to be co-expressed with TOX in tumour samples, but not in normal skin and atopic dermatitis, and as a result, they have a potential to be a diagnostic marker in CTCL. The gene discussed is TOX; the disease is neoplasm.